机构:[1]Medical Science Research Center, Zhongnan Hospital, School of Basic Medical Sciences, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China[3]Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China[4]College of Life Sciences, Wuhan University, Wuhan, China[5]Tongren Hospital of Wuhan University and Wuhan Third Hospital, Wuhan, China.
Background and Aims Hepatic ischemia/reperfusion (I/R) injury, a common clinical problem that occurs during liver surgical procedures, causes a large proportion of early graft failure and organ rejection cases. The identification of key regulators of hepatic I/R injury may provide potential strategies to clinically improve the prognosis of liver surgery. Here, we aimed to identify the role of tumor necrosis factor alpha-induced protein 3-interacting protein 3 (TNIP3) in hepatic I/R injury and further reveal its immanent mechanisms. Approach and Results In the present study, we found that hepatocyte TNIP3 was markedly up-regulated in livers of both persons and mice subjected to I/R surgery. Hepatocyte-specific Tnip3 overexpression effectively attenuated I/R-induced liver necrosis and inflammation, but improved cell proliferation in mice, whereas TNIP3 ablation largely aggravated liver injury. This inhibitory effect of TNIP3 on hepatic I/R injury was found to be dependent on significant activation of the Hippo-YAP signaling pathway. Mechanistically, TNIP3 was found to directly interact with large tumor suppressor 2 (LATS2) and promote neuronal precursor cell-expressed developmentally down-regulated 4-mediated LATS2 ubiquitination, leading to decreased Yes-associated protein (YAP) phosphorylation at serine 112 and the activated transcription of factors downstream of YAP. Notably, adeno-associated virus delivered TNIP3 expression in the liver substantially blocked I/R injury in mice. Conclusions TNIP3 is a regulator of hepatic I/R injury that alleviates cell death and inflammation by assisting ubiquitination and degradation of LATS2 and the resultant YAP activation.TNIP3 represents a promising therapeutic target for hepatic I/R injury to improve the prognosis of liver surgery.
基金:
National Key R&D Program of China [2016YFF0101504]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82000550, 82000546, 81630011, 81970011]; Hubei Science and Technology Support Project [2017BEC001]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042019kf0175]
第一作者机构:[1]Medical Science Research Center, Zhongnan Hospital, School of Basic Medical Sciences, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China
共同第一作者:
通讯作者:
通讯机构:[1]Medical Science Research Center, Zhongnan Hospital, School of Basic Medical Sciences, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China[3]Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China[*1]Department of Cardiology Renmin Hospital of Wuhan University No. 238 Jie-Fang Road Wuhan 430060, China[*2]Department of Cardiology Renmin Hospital of Wuhan University No. 238 Jie-Fang Road Wuhan 430060, China[*3]Basic Medical School, Wuhan University No. 185 Donghu Road Wuhan 430071, China
推荐引用方式(GB/T 7714):
Zhou Junjie,Hu Manli,He Meiling,et al.TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury[J].HEPATOLOGY.2021,74(4):2133-2153.doi:10.1002/hep.32015.
APA:
Zhou, Junjie,Hu, Manli,He, Meiling,Wang, Xiaoming,Sun, Dating...&Zhang, Peng.(2021).TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.HEPATOLOGY,74,(4)
MLA:
Zhou, Junjie,et al."TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury".HEPATOLOGY 74..4(2021):2133-2153